Editing Déjà vu (section)

==Pharmacology==
Certain combinations of medical drugs have been reported to increase the chances of ''déjà vu'' occurring in the user. Taiminen and Jääskeläinen (2001)<ref>{{Cite journal
| last1 = Taiminen | first1 = T.S.
| title = Intense and recurrent déjà vu experiences related to amantadine and phenylpropanolamine in a healthy male
| journal = Journal of Clinical Neuroscience
| volume = 8
| last2 = Jääskeläinen
| issue = 5
| pages = 460–462
| year = 2001
| pmid = 11535020
| doi = 10.1054/jocn.2000.0810
| s2cid = 6733989
}}</ref> explored the case of an otherwise healthy person who started experiencing intense and recurrent sensations of ''déjà vu'' upon taking the drugs [[amantadine]] and [[phenylpropanolamine]] together to relieve flu symptoms. Because of the [[dopaminergic]] action of the drugs and previous findings from electrode stimulation of the brain (e.g. Bancaud, Brunet-Bourgin, Chauvel, & Halgren, 1994),<ref>{{Cite journal
| doi = 10.1093/brain/117.1.71
| pmid = 8149215
| year = 1994
| last1 = Bancaud | first1 = J.
| last2 = Brunet-Bourgin | first2 = F.
| last3 = Chauvel | first3 = P.
| last4 = Halgren | first4 = E.
| title = Anatomical origin of déjà vu and vivid 'memories' in human temporal lobe epilepsy
| volume = 117
| pages = 71–90
| journal = Brain: A Journal of Neurology
 | issue=1
}}</ref> Tamminen and Jääskeläinen speculated that ''déjà vu'' occurs as a result of hyperdopaminergic [[Mesial temporal lobe epilepsy|action]] in the medial [[Temporal lobe|temporal]] areas of the brain. A similar case study by Karla, Chancellor, and Zeman (2007) suggests a link between ''déjà vu'' and the [[Serotonin|serotonergic system]], after an otherwise healthy woman began experiencing similar symptoms while taking a combination of [[5-Hydroxytryptophan|5-hydroxytryptophan]] and [[carbidopa]].<ref>{{Cite journal |last1=Kalra |first1=Seema |last2=Chancellor |first2=Andrew |last3=Zeman |first3=Adam |date=2007 |title=Recurring déjà vu associated with 5-hydroxytryptophan |url=https://www.cambridge.org/core/product/identifier/S0924270800002623/type/journal_article |journal=Acta Neuropsychiatrica |language=en |volume=19 |issue=5 |pages=311–313 |doi=10.1111/j.1601-5215.2007.00245.x |pmid=26952944 |s2cid=41092669 |issn=0924-2708}}</ref>